4.7 Review

What lysosomes actually tell us about Parkinson's disease?

期刊

AGEING RESEARCH REVIEWS
卷 32, 期 -, 页码 140-149

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.arr.2016.02.008

关键词

Parkinson's disease; Lysosomes; Neurodegeneration; Therapeutic

资金

  1. Marie Curie Reintegration Grant from the European Commission [FP7-PEOPLE-2009-ERG256303]
  2. PEPS-Idex [1024R-3219]
  3. Fondation pour la Recherche Medicale
  4. MESR fellowship
  5. France Parkinson Foundation

向作者/读者索取更多资源

Parkinson's disease is a common neurodegenerative disorder of unknown origin mainly characterized by the loss of neuromelanin-containing dopaminergic neurons in the substantia nigra pars compacta and the presence of intraneuronal proteinaceous inclusions called Lewy bodies. Lysosomes are dynamic organelles that degrade, in a controlled manner, cellular components delivered via the secretory, endocytic, autophagic and phagocytic membrane-trafficking pathways. Increasing amounts of evidence suggest a central role of lysosomal impairment in PD aetiology. This review provides an update on how genetic evidence support this connection and highlights how the neuropathologic and mechanistic evidence might relate to the disease process in sporadic forms of Parkinson's disease. Finally, we discuss the influence of ageing on lysosomal impairment and PD aetiology and therapeutic strategies targeting lysosomal function. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据